3,4‐Diaminopyridine vs placeboImprovement in mean CMAP amplitude (mV) · participants with Lambert‐Eaton myasthenic syndrome1 finding from 1 reviewTreatment for Lambert‐Eaton myasthenic syndrome 2011 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 94 participantsHigh